Zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (MZL): final analysis of MAGNOLIA (BGB-3111-214)
Authors
Linton, Kim MTrotman, J
McKay, P
Ardeshna, K
Iyengar, S
Tedeschi, A
Hu, B
Leitch, S
Jin, J
Sun, M
Sobieraj-Teague, M
Zinzani, PL
Browett, P
Ke, X
Portell, CA
Thieblemont, C
Bijou, F
Walker, P
Hawkes, EA
Ho, SJ
Zhou, KS
Liang, ZY
Xu, JF
Tankersley, C
Delarue, R
Co, M
Opat, S
Affiliation
Manchester Cancer Research Centre, Division Of Cancer Sciences, Manchester, UKIssue Date
2023